Cancers (Aug 2022)
Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. <i>Cancers</i> 2021, <i>13</i>, 5939
- Anke Brüning-Richardson,
- Gary C. Shaw,
- Daniel Tams,
- Tim Brend,
- Hitesh Sanganee,
- Simon T. Barry,
- Gregory Hamm,
- Richard J. A. Goodwin,
- John G. Swales,
- Henry King,
- Lynette Steele,
- Ruth Morton,
- Anastasia Widyadari,
- Thomas A. Ward,
- Filomena Esteves,
- Marjorie Boissinot,
- Georgia Mavria,
- Alastair Droop,
- Sean E. Lawler,
- Susan C. Short
Affiliations
- Anke Brüning-Richardson
- Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds LS9 7TF, UK
- Gary C. Shaw
- Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds LS9 7TF, UK
- Daniel Tams
- Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds LS9 7TF, UK
- Tim Brend
- Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds LS9 7TF, UK
- Hitesh Sanganee
- Discovery Sciences BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK
- Simon T. Barry
- Bioscience, Early Oncology, Oncology R&D, AstraZeneca, Cambridge CB2 8PA, UK
- Gregory Hamm
- Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK
- Richard J. A. Goodwin
- Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK
- John G. Swales
- Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK
- Henry King
- Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds LS9 7TF, UK
- Lynette Steele
- Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds LS9 7TF, UK
- Ruth Morton
- Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds LS9 7TF, UK
- Anastasia Widyadari
- Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds LS9 7TF, UK
- Thomas A. Ward
- Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds LS9 7TF, UK
- Filomena Esteves
- Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds LS9 7TF, UK
- Marjorie Boissinot
- Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds LS9 7TF, UK
- Georgia Mavria
- Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds LS9 7TF, UK
- Alastair Droop
- Leeds MRC Medical Bioinformatics Centre, University of Leeds, Leeds LS9 7TF, UK
- Sean E. Lawler
- Pathology & Laboratory Medicine, Brown University Cancer Center, Brown University, Providence, RI 02903, USA
- Susan C. Short
- Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds LS9 7TF, UK
- DOI
- https://doi.org/10.3390/cancers14153789
- Journal volume & issue
-
Vol. 14,
no. 15
p. 3789
Abstract
The authors wish to make the following corrections to this paper [1] [...]
Keywords
